Pangea will be presenting posters at the 2025 ASCO Annual Meeting in Chicago this month. Poster presentation details are as follows:
Title: Predication of clinical outcomes of advanced cutaneous squamous cell carcinoma to PD1 inhibition directly from histopathology slides using inferred transcriptomics
Track: Developmental Therapeutics—Immunotherapy
Date/Time: June 2, 2025, 1:30pm – 4:30pm CT
Abstract: 2630
Poster Board Number: 277
Title: Validation of ENLIGHT, an AI predictor of immune checkpoint blockade (ICB) response and resistance, across the treatment span
Track: Developmental Therapeutics—Immunotherapy
Date/Time: June 2, 2025, 1:30pm – 4:30pm CT
Abstract: 2632
Poster Board Number: 279
We look forward to seeing you there!